Safety Concerns for Sclerotherapy of Telangiectases, Reticular and Varicose Veins
Conclusion: Physicians practicing sclerotherapy should be aware of the possible local and systemic AE of sclerotherapy, inform patients accordingly and be prepared for the appropriate management of the rare but possibly lethal serious AE.Pharmacology 2016;98:62-69
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Anaphylactic Shock | Cardiology | Cardiomyopathy | Databases & Libraries | Drugs & Pharmacology | Heart | Heart Attack | Hypertrichosis | Ischemic Stroke | Neurology | Pain | Pain Management | Pulmonary Thromboembolism | Stroke | Thrombosis | Toxicology | Varicose Veins